Dödligt virus från Kina orsakar panik (SARS-CoV-2, COVID-19)

Fauci’s Remdesivir: Inadequate to Treat COVID-19 and Potentially Lethal

An Analysis of the Science and Politics

By Peter R. Breggin, MD and Ginger Ross Breggin
May 14, 2020

We have found that remdesivir is a failed antiviral drug that will probably do more harm than good for many coronavirus patients. An earlier remdesivir trial for Ebola was stopped because the drug was causing significantly higher mortality rates than other antiviral drugs in the same trial. As one recent medical source noted, the remdesivir Ebola trial had to be aborted “because of an increase in death among patients taking it, meaning it did not help those patients”.

The UK’s National Institute of Health and Care Excellence (Nice) is on the verge of approving a weekly jab in an effort to shrink the ever-growing waistlines of the nation, according to The Telegraph on Tuesday.

Trials showed the treatment, known as Wegovy, to be as effective as a gastric band. On average, trialists lost almost 2.5 stone (15.8kg), compared with those given a placebo. It was hailed as “game-changer” last year by researchers.

Wegovy™ may cause serious side effects, including:
Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy™ and medicines that work like Wegovy™ caused thyroid tumors, including thyroid cancer. It is not known if Wegovy™ will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.